198 related articles for article (PubMed ID: 25817870)
21. How to help the aging male? Current approaches to hypogonadism in primary care.
Lunenfeld B; Arver S; Moncada I; Rees DA; Schulte HM
Aging Male; 2012 Dec; 15(4):187-97. PubMed ID: 23067307
[TBL] [Abstract][Full Text] [Related]
22. Leydig cells: formation, function, and regulation.
Zirkin BR; Papadopoulos V
Biol Reprod; 2018 Jul; 99(1):101-111. PubMed ID: 29566165
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular benefits and risks of testosterone replacement therapy in older men with low testosterone.
Chrysant SG; Chrysant GS
Hosp Pract (1995); 2018 Apr; 46(2):47-55. PubMed ID: 29478348
[TBL] [Abstract][Full Text] [Related]
24. Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel.
Kaminetsky J; Werner M; Fontenot G; Wiehle RD
J Sex Med; 2013 Jun; 10(6):1628-35. PubMed ID: 23530575
[TBL] [Abstract][Full Text] [Related]
25. The role of testosterone replacement therapy following radical prostatectomy.
Khera M; Lipshultz LI
Urol Clin North Am; 2007 Nov; 34(4):549-53, vi. PubMed ID: 17983894
[TBL] [Abstract][Full Text] [Related]
26. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
[TBL] [Abstract][Full Text] [Related]
27. Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone.
Reyes-Vallejo L; Lazarou S; Morgentaler A
J Sex Med; 2007 Nov; 4(6):1757-62. PubMed ID: 17087806
[TBL] [Abstract][Full Text] [Related]
28. Body composition changes with testosterone replacement therapy following spinal cord injury and aging: A mini review.
Nightingale TE; Moore P; Harman J; Khalil R; Gill RS; Castillo T; Adler RA; Gorgey AS
J Spinal Cord Med; 2018 Nov; 41(6):624-636. PubMed ID: 28770686
[TBL] [Abstract][Full Text] [Related]
29. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters.
Yassin A; Nettleship JE; Talib RA; Almehmadi Y; Doros G
Aging Male; 2016; 19(1):64-9. PubMed ID: 26742589
[TBL] [Abstract][Full Text] [Related]
30. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.
Debruyne FM; Behre HM; Roehrborn CG; Maggi M; Wu FC; Schröder FH; Jones TH; Porst H; Hackett G; Wheaton OA; Martin-Morales A; Meuleman E; Cunningham GR; Divan HA; Rosen RC;
BJU Int; 2017 Feb; 119(2):216-224. PubMed ID: 27409523
[TBL] [Abstract][Full Text] [Related]
31. Testosterone deficiency in older men: a problem worth treating.
McHenry Martin C
Consult Pharm; 2012 Mar; 27(3):152-63. PubMed ID: 22421515
[TBL] [Abstract][Full Text] [Related]
32. Effects of testosterone replacement therapy on metabolic syndrome among Japanese hypogonadal men: A subanalysis of a prospective randomised controlled trial (EARTH study).
Shigehara K; Konaka H; Nohara T; Izumi K; Kitagawa Y; Kadono Y; Iwamoto T; Koh E; Mizokami A; Namiki M
Andrologia; 2018 Feb; 50(1):. PubMed ID: 28497534
[TBL] [Abstract][Full Text] [Related]
33. Induction of androgen formation in the male by a TAT-VDAC1 fusion peptide blocking 14-3-3ɛ protein adaptor and mitochondrial VDAC1 interactions.
Aghazadeh Y; Martinez-Arguelles DB; Fan J; Culty M; Papadopoulos V
Mol Ther; 2014 Oct; 22(10):1779-91. PubMed ID: 24947306
[TBL] [Abstract][Full Text] [Related]
34. Late-onset hypogonadism and lifestyle-related metabolic disorders.
Braga PC; Pereira SC; Ribeiro JC; Sousa M; Monteiro MP; Oliveira PF; Alves MG
Andrology; 2020 Nov; 8(6):1530-1538. PubMed ID: 31991053
[TBL] [Abstract][Full Text] [Related]
35. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin S; Brito JP; Cunningham GR; Hayes FJ; Hodis HN; Matsumoto AM; Snyder PJ; Swerdloff RS; Wu FC; Yialamas MA
J Clin Endocrinol Metab; 2018 May; 103(5):1715-1744. PubMed ID: 29562364
[TBL] [Abstract][Full Text] [Related]
36. Age-related androgen deficiency and type 2 diabetes.
Ryan GJ; Jobe LJ
J Pharm Pract; 2011 Jun; 24(3):316-22. PubMed ID: 21676855
[TBL] [Abstract][Full Text] [Related]
37. Testosterone replacement therapy in males with erectile dysfunction.
Jacob BC
J Pharm Pract; 2011 Jun; 24(3):298-306. PubMed ID: 21676853
[TBL] [Abstract][Full Text] [Related]
38. The Role of Testosterone in the Elderly: What Do We Know?
Barone B; Napolitano L; Abate M; Cirillo L; Reccia P; Passaro F; Turco C; Morra S; Mastrangelo F; Scarpato A; Amicuzi U; Morgera V; Romano L; Calace FP; Pandolfo SD; De Luca L; Aveta A; Sicignano E; Trivellato M; Spena G; D'Alterio C; Fusco GM; Vitale R; Arcaniolo D; Crocetto F
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408895
[TBL] [Abstract][Full Text] [Related]
39. Effects of testosterone replacement in hypogonadal men.
Snyder PJ; Peachey H; Berlin JA; Hannoush P; Haddad G; Dlewati A; Santanna J; Loh L; Lenrow DA; Holmes JH; Kapoor SC; Atkinson LE; Strom BL
J Clin Endocrinol Metab; 2000 Aug; 85(8):2670-7. PubMed ID: 10946864
[TBL] [Abstract][Full Text] [Related]
40. Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus - a series of case reports.
Saad F; Yassin A; Almehmadi Y; Doros G; Gooren L
Aging Male; 2015; 18(3):164-8. PubMed ID: 26075537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
